EUVIMEDEUVIMED entdecken
Übersichtsarbeit

HTLV‐1 persistent infection and ATLL oncogenesis

Xiaorui Zuo, Ruoning Zhou, Sikai Yang, Guangyong Ma iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Xiaorui Zuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Science, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Human T-lymphotropic virus 1. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Pharmaceutical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human T‐cell leukemia virus type 1 (HTLV‐1) is an oncogenic retrovirus; whereas HTLV‐1 mainly persists in the infected host cell as a provirus, it also causes a malignancy called adult T‐cell leukemia/lymphoma (ATLL) in about 5% of infection. HTLV‐1 replication is in most cases silent in vivo and viral de novo infection rarely occurs; HTLV‐1 rather relies on clonal proliferation of infected T cells for viral propagation as it multiplies the number of the provirus copies. It is mechanistically elusive how leukemic clones emerge during the course of HTLV‐1 infection in vivo and eventually cause the onset of ATLL. This review summarizes our current understanding of HTLV‐1 persistence and oncogenesis, with the incorporation of recent cutting‐edge discoveries obtained by high‐throughput sequencing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia-Lymphoma, Adult T-CellHuman T-lymphotropic virus 1AdultHumansPersistent InfectionT-LymphocytesCarcinogenesisProvirusesCell Transformation, Neoplastic

Stichwörter der Autor:innen

ATLLHBZHTLV-1clonalitypersistencetax

Autor:innen und Institutionen

  • Institute of Pharmaceutical Science, China Pharmaceutical University, Nanjing, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Guangyong Ma

Förderung

  • National Natural Science Foundation of China
  • China Pharmaceutical University

Zitieren

APA

Zuo, X., Zhou, R., Yang, S., & Ma, G. (2023). HTLV‐1 persistent infection and ATLL oncogenesis. Journal of Medical Virology. https://doi.org/10.1002/jmv.28424

Vancouver

Zuo X, Zhou R, Yang S, Ma G. HTLV‐1 persistent infection and ATLL oncogenesis. Journal of Medical Virology. 2023. doi:10.1002/jmv.28424

BibTeX
@article{Zuo2023,
  author = {Zuo, Xiaorui and Zhou, Ruoning and Yang, Sikai and Ma, Guangyong},
  title = {HTLV‐1 persistent infection and ATLL oncogenesis},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28424}
}
Kostenlos starten →